10/25/24 17:42 | 10/18/24 | APRE | Health | Drug | Pharmaceutical Preparations | Duey Marc | PA | D | | S | -30 | 4.58 | 0 | -6 | -3 | 234 | D | | | | | | | | | | | | | | |
10/24/24 08:30 | 10/23/24 | APRE | Health | Drug | Pharmaceutical Preparations | Gilad Oren | PA | DO | P,CEO | P | 2 | 3.92 | 0 | 1 | 0 | 335 | D | | | | | | | | | | | | | | |
10/17/24 08:30 | 10/16/24 | APRE | Health | Drug | Pharmaceutical Preparations | Duey Marc | PA | D | | P | 132 | 4.39 | 0 | 30 | 14 | 241 | D | | | | | | | | | | | | | | |
10/16/24 08:31 | 10/15/24 | APRE | Health | Drug | Pharmaceutical Preparations | Gilad Oren | PA | DO | P,CEO | P | 1 | 2.90 | 0 | 0 | 0 | 335 | D | | | | | | | | | | | | | | |
10/16/24 08:30 | 10/14/24 | APRE | Health | Drug | Pharmaceutical Preparations | Duey Marc | PA | D | | P | 0 | 2.58 | 0 | 0 | 0 | 211 | D | | | | | | | | | | | | | | |
10/16/24 08:30 | 10/11/24 | APRE | Health | Drug | Pharmaceutical Preparations | Hamill John P. | PA | O | SrVP,CFO | P | 0 | 2.46 | 0 | 0 | 0 | 19 | D | | | | | | | | | | | | | | |
10/15/24 08:31 | 10/11/24 | APRE | Health | Drug | Pharmaceutical Preparations | Seizinger Bernd R. | PA | D | | P | 27 | 2.68 | 0 | 10 | 29 | 45 | D | | | | | | | | | | | | | | |
10/15/24 08:31 | 10/10/24 | APRE | Health | Drug | Pharmaceutical Preparations | Gilad Oren | PA | DO | P,CEO | P.m | 3 | 2.58 | 0 | 1 | 0 | 334 | D | | | | | | | | | | | | | | |
10/15/24 08:30 | 10/10/24 | APRE | Health | Drug | Pharmaceutical Preparations | Hamill John P. | PA | O | SrVP,CFO | P | 1 | 2.61 | 0 | 0 | 2 | 19 | D | | | | | | | | | | | | | | |
3/14/24 20:54 | 3/13/24 | APRE | Health | Drug | Pharmaceutical Preparations | Hamill John P. | PA | O | SrVP,CFO | P.d | 7 | 7.29 | 0 | 1 | 7 | 16 | D | | | | | | | | | | | | | | |
3/14/24 20:53 | 3/13/24 | APRE | Health | Drug | Pharmaceutical Preparations | Seizinger Bernd R. | PA | D | | P.d | 50 | 7.29 | 0 | 7 | 26 | 34 | D | | | | | | | | | | | | | | |
3/14/24 20:52 | 3/13/24 | APRE | Health | Drug | Pharmaceutical Preparations | Henneman John B III | PA | D | | P.d | 50 | 7.29 | 0 | 7 | 536 | 8 | D | | | | | | | | | | | | | | |
3/14/24 20:51 | 3/13/24 | APRE | Health | Drug | Pharmaceutical Preparations | Gilad Oren | PA | DO | P,CEO | P.d | 15 | 7.29 | 0 | 2 | 1 | 325 | D | | | | | | | | | | | | | | |
6/8/23 16:34 | 6/6/23 | APRE | Health | Drug | Pharmaceutical Preparations | Seizinger Bernd R. | PA | D | | P.m | 37 | 3.66 | 0 | 10 | 62 | 26 | D | | | | | | | | | | | | | | |
5/19/22 16:31 | 5/18/22 | APRE | Health | Drug | Pharmaceutical Preparations | Seizinger Bernd R. | MA | D | | P | 36 | 0.7100 | 0 | 50 | 19 | 319 | D | | | | | | | | | | | | | | |
5/19/22 16:30 | 5/18/22 | APRE | Health | Drug | Pharmaceutical Preparations | Schade Christian S | MA | DO | CB,CEO | P | 24 | 0.6433 | 0 | 38 | 14 | 304 | D | | | | | | | | | | | | | | |